Clinical Trial Update: Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

View source ↗

Summary

Post-market, multi-center prospective study evaluating long-term outcomes in non-melanoma skin cancer patients treated with the electronic brachytherapy system …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• eBx (electronic brachytherapy system) (electronic brachytherapy)

Snippet

Sponsor: Xoft, Inc. | Conditions: Non-melanoma Skin Cancer | Status: COMPLETED | Results posted: 2025-01-13